Federal Reports

What We Looked At
The Office of National Drug Control Policy (ONDCP) advises the President on drug control issues and is responsible for developing and implementing the National Drug Control Strategy (the Strategy), a comprehensive plan with long-range goals for reducing drug abuse and its consequences in the United States. To carry out the Strategy's goals, ONDCP works with more than a dozen Federal agencies-including the National Highway Traffic Safety Administration (NHTSA)-through the National Drug Control Program (NDCP). We most recently reviewed NHTSA's NDCP activities for fiscal year 2019, identifying errors and omissions in the Agency's reports. Given the length of time since our last review and issues it identified, we self-initiated this performance audit. Our objective was to assess NHTSA's internal controls over its NDCP activity. Specifically, we looked at NHTSA's (1) controls for tracking drug control obligations and consistently reporting to ONDCP and (2) documentation to show compliance with drug control budget formulation requirements.

What We Found
NHTSA lacks controls for tracking and consistently reporting drug control-related obligations as required. Instead, the Agency relies on the expertise of its staff to estimate drug control-related obligations; however, staff used varying methodologies when contracts addressed multiple areas and inconsistently reported contract obligation amounts. As a result, ONDCP cannot rely on the accuracy of NHTSA's reported drug control-related obligations, inhibiting ONDCP's ability to accurately inform Congress and the public about the funds NHTSA spent on drug control activities. In addition, NHTSA lacks documentation to show it complies with drug control budget formulation requirements. NHTSA does not have formal written approval for its methodology from ONDCP and could not provide documentation to support how it calculated the budget estimates reported to ONDCP. As a result, NHTSA cannot ensure its budget estimates reasonably and fairly quantify funding that the Agency will use for drug control activities.

Our Recommendations
We made four recommendations to improve NHTSA's internal controls of drug control-related reporting. The Agency concurred with all four of our recommendations. We consider recommendations 1, 2, and 4 resolved but open pending completion of the planned actions and recommendation 3 resolved and closed.

We determined that the EPA awarded WIIN Act funds consistent with nearly all guidance and improved Agency processes to increase the transparency of funding decisions. We identified two documentation issues that the EPA experienced before it awarded funds. Agency staff reported to us that they had addressed one of these issues with additional controls and a new oversight structure within the Office of Water, or the OW, and the other through a new standard operating procedure within the Office of Grants and Debarment.

To see our report, click on the link below

VA’s Veterans Transportation Program offers travel solutions for veterans to get to and from VA healthcare facilities at little or no cost to veterans. One travel option is transportation by wheelchair van. VA’s Health Administration Service is responsible for administering the contracts that provide wheelchair-accessible transportation services for veterans to access VA medical facilities in the healthcare system.The OIG conducted this review because of a hotline referral that alleged mismanagement of contracts for wheelchair transportation services at the Dallas VA Medical Center in VA’s North Texas Health Care System. The OIG substantiated the allegation that Health Administration Service officials mismanaged the contracts and found that staff overpaid the contractor approximately 30 percent, or $3.7 million, for mileage overcharges and duplicate invoices. Certifying officials did not verify invoices and relied on program assistants to approve or deny invoices for certification. In addition, a manager who plays a key role in the program’s operations did not ensure staff followed VA’s financial policy for reviewing and certifying invoices or provide certifying officials with the current contract rates or a standard operating procedure.The OIG recommended that the Dallas medical center director, with the Health Administration Service chief, develop local policy and standard operating procedures to ensure invoices are adequately reviewed before payment is made. The OIG also recommended that the Health Administration Service chief recover approximately $3.7 million in overpayments.